Ohlstein EH - Search Results

1

Pharmacology of a potent long-acting imidazole-5-acrylic acid angiotensin AT1 receptor antagonist.

Aiyar N, Baker E, Vickery-Clark L, Ohlstein EH, Gellai M, Fredrickson TA, Brooks DP, Weinstock J, Weidley EF, Edwards RM. Aiyar N, et al. Among authors: ohlstein eh. Eur J Pharmacol. 1995 Sep 5;283(1-3):63-72. doi: 10.1016/0014-2999(95)00287-u. Eur J Pharmacol. 1995. PMID: 7498322

2

Nonpeptide endothelin receptor antagonists. VII: Binding characteristics of [3H]SB 209670, a novel nonpeptide antagonist of endothelin receptors.

Nambi P, Pullen M, Wu HL, Lee D, Saunders D, Heys R, Aiyar N, Leber J, Elliott J, Brooks D, Ohlstein E, Ruffolo R. Nambi P, et al. J Pharmacol Exp Ther. 1996 Jun;277(3):1567-71. J Pharmacol Exp Ther. 1996. PMID: 8667224

3

Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.

Edwards RM, Aiyar N, Ohlstein EH, Weidley EF, Griffin E, Ezekiel M, Keenan RM, Ruffolo RR, Weinstock J. Edwards RM, et al. Among authors: ohlstein eh. J Pharmacol Exp Ther. 1992 Jan;260(1):175-81. J Pharmacol Exp Ther. 1992. PMID: 1309870

4

The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.

Ohlstein EH, Gellai M, Brooks DP, Vickery L, Jugus J, Sulpizio A, Ruffolo RR Jr, Weinstock J, Edwards RM. Ohlstein EH, et al. J Pharmacol Exp Ther. 1992 Aug;262(2):595-601. J Pharmacol Exp Ther. 1992. PMID: 1501114

5

Antihypertensive effects of the endothelin receptor antagonist BQ-123 in conscious spontaneously hypertensive rats.

Ohlstein EH, Douglas SA, Ezekiel M, Gellai M. Ohlstein EH, et al. J Cardiovasc Pharmacol. 1993;22 Suppl 8:S321-4. doi: 10.1097/00005344-199322008-00084. J Cardiovasc Pharmacol. 1993. PMID: 7509976

6

Functional evidence that balloon angioplasty results in transient nitric oxide synthase induction.

Douglas SA, Vickery-Clark LM, Ohlstein EH. Douglas SA, et al. Among authors: ohlstein eh. Eur J Pharmacol. 1994 Apr 1;255(1-3):81-9. doi: 10.1016/0014-2999(94)90085-x. Eur J Pharmacol. 1994. PMID: 7517884

7

In vivo pharmacological characterization of the non-peptide endothelin receptor antagonist SB 209670.

Douglas SA, Edwards RM, Elliott JD, Ohlstein EH. Douglas SA, et al. Among authors: ohlstein eh. Br J Pharmacol. 1995 Jan;114(2):405-13. doi: 10.1111/j.1476-5381.1995.tb13241.x. Br J Pharmacol. 1995. PMID: 7881741 Free PMC article.

8

SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist.

Ohlstein EH, Nambi P, Douglas SA, Edwards RM, Gellai M, Lago A, Leber JD, Cousins RD, Gao A, Frazee JS, et al. Ohlstein EH, et al. Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8052-6. doi: 10.1073/pnas.91.17.8052. Proc Natl Acad Sci U S A. 1994. PMID: 8058755 Free PMC article.

9

Endothelin-1 does not mediate hypoxic vasoconstriction in canine isolated blood vessels: effect of BQ-123.

Douglas SA, Vickery-Clark LM, Ohlstein EH. Douglas SA, et al. Among authors: ohlstein eh. Br J Pharmacol. 1993 Feb;108(2):418-21. doi: 10.1111/j.1476-5381.1993.tb12819.x. Br J Pharmacol. 1993. PMID: 8448593 Free PMC article.

10

Endothelin receptor subtypes in the pathogenesis of angioplasty-induced neointima formation in the rat: a comparison of selective ETA receptor antagonism and dual ETA/ETB receptor antagonism using BQ-123 and SB 209670.

Douglas SA, Vickery-Clark LM, Louden C, Elliott JD, Ohlstein EH. Douglas SA, et al. Among authors: ohlstein eh. J Cardiovasc Pharmacol. 1995;26 Suppl 3:S186-9. J Cardiovasc Pharmacol. 1995. PMID: 8587358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters